Cargando…
Preclinical validation of a live attenuated dermotropic Leishmania vaccine against vector transmitted fatal visceral leishmaniasis
Visceral Leishmaniasis (VL), a potentially fatal disease is caused by Leishmania donovani parasites with no vaccine available. Here we produced a dermotropic live attenuated centrin gene deleted Leishmania major (LmCen(−/−)) vaccine under Good Laboratory Practices and demonstrated that a single intr...
Autores principales: | Karmakar, Subir, Ismail, Nevien, Oliveira, Fabiano, Oristian, James, Zhang, Wen Wei, Kaviraj, Swarnendu, Singh, Kamaleshwar P., Mondal, Abhishek, Das, Sushmita, Pandey, Krishna, Bhattacharya, Parna, Volpedo, Greta, Gannavaram, Sreenivas, Satoskar, Monika, Satoskar, Sanika, Sastry, Rajiv M., Oljuskin, Timur, Sepahpour, Telly, Meneses, Claudio, Hamano, Shinjiro, Das, Pradeep, Matlashewski, Greg, Singh, Sanjay, Kamhawi, Shaden, Dey, Ranadhir, Valenzuela, Jesus G., Satoskar, Abhay, Nakhasi, Hira L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8324786/ https://www.ncbi.nlm.nih.gov/pubmed/34330999 http://dx.doi.org/10.1038/s42003-021-02446-x |
Ejemplares similares
-
Leishmania Major Centrin Gene-Deleted Parasites Generate Skin Resident Memory T-Cell Immune Response Analogous to Leishmanization
por: Ismail, Nevien, et al.
Publicado: (2022) -
Leishmania major centrin knock-out parasites reprogram tryptophan metabolism to induce a pro-inflammatory response
por: Oljuskin, Timur, et al.
Publicado: (2023) -
Production of leishmanin skin test antigen from Leishmania donovani for future reintroduction in the field
por: Dey, Ranadhir, et al.
Publicado: (2023) -
Determinants of Innate Immunity in Visceral Leishmaniasis and Their Implication in Vaccine Development
por: Volpedo, Greta, et al.
Publicado: (2021) -
The History of Live Attenuated Centrin Gene-Deleted Leishmania Vaccine Candidates
por: Volpedo, Greta, et al.
Publicado: (2022)